BENZAMIDE IMIDAZOPYRAZINE BTK INHIBITORS

The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts thereof, or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the...

Full description

Saved in:
Bibliographic Details
Main Authors WANG, Dahai, WU, Hao, LIU, Shilan, WANG, Jyhshing, KOZLOWSKI, Joseph, A, GUIADEEN, Deodialsingh, LIU, Jian, BOGA, Sobhana Babu, CAI, Jiaqiang, ALHASSAN, Abdul-Basit, YANG, Chundao, YU, Wensheng, GAO, Xiaolei
Format Patent
LanguageEnglish
French
German
Published 01.11.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts thereof, or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds of Formula (I) in the treatment of Btk mediated disorders.
Bibliography:Application Number: EP20150875975